<?xml version="1.0" encoding="UTF-8"?>
<p>Vitamin C, also known as ascorbic acid, has antioxidant properties and plays a significant role in reducing inflammatory response. Studies have shown that ascorbic acid down-regulates the production of pro-inflammatory cytokines (
 <xref rid="B115" ref-type="bibr">115</xref>). These concepts have generated interest in the use of ascorbic acid in the management of inflammatory conditions. In a recent randomized clinical trial involving 167 patients in the intensive care unit, intravenous infusion of high-dose ascorbic acid compared to placebo did not significantly reduce organ dysfunction scores or improve levels of biomarkers indicating inflammation among patients with sepsis and ARDS, two disease processes heavily associated with inflammation (
 <xref rid="B116" ref-type="bibr">116</xref>). A randomized controlled trial is currently underway and in phase 2 to study the clinical efficacy and safety of vitamin C infusion for treatment of COVID-19 pneumonia (
 <xref rid="B117" ref-type="bibr">117</xref>).
</p>
